SAM
IRWD icon

Symphony Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Symphony Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-135,041
Closed -$2.09M – 192
2018
Q3 		$2.09M Hold
135,041
– – 0.56% 22
2018
Q2 		$2.16M Buy
+135,041
New +$2M 0.43% 49

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Symphony Asset Management's IRWD Position: Q4 2018 in Review

Symphony Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2018, closing a stake of 135,041 shares — an estimated $2.09M sold.

Symphony Asset Management first reported a position in IRWD in Q2 2018 and held it in 2 quarters. The position peaked at $2.16M in Q2 2018. 145 funds tracked by Wall St. Rank hold IRWD as of Q4 2018.

  • Symphony Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Symphony Asset Management sold 135,041 Ironwood Pharmaceuticals shares in Q4 2018, an estimated $2.09M.
  • Symphony Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2018 and held it in 2 quarters.
  • Symphony Asset Management's Ironwood Pharmaceuticals position peaked at $2.16M in Q2 2018.
  • 145 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2018.

Based on Symphony Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.